VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q3 2022

SEC EDGAR SourceSEC Filings

Top Holdings10 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

449,460$161.2M29.4%$373.02-6.76%
10 qtrssince 2020-Q2
Decreased
0
AGGAGG
ETF

ISHARES TR

1.1M$101.6M18.5%$96.02-12.81%
10 qtrssince 2020-Q2
Increased
72
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

448,300$94.3M17.2%$209.990.00%
1 qtr
New
95
TLTTLT
ETF

ISHARES 20 PLUS YEAR TREASURY BD

703,235$72M13.1%$95.82-8.34%
2 qtrssince 2022-Q2
Increased
74
VUGVUG
ETF

VANGUARD GROWTH ETF

231,800$49.6M9.0%$34.940.00%
1 qtr
New
93
282,350$21.1M3.8%
2 qtrssince 2022-Q2
Decreased
0
VCSHVCSH
ETF

VANGUARD S/T CORP BOND ETF

278,410$20.7M3.8%$65.38-2.11%
2 qtrssince 2022-Q2
Decreased
0
IGSBIGSB
ETF

ISHARES 1-5Y INV GRADE CORP

219,740$10.8M2.0%$43.14-2.02%
2 qtrssince 2022-Q2
Decreased
0
VTVVTV
ETF

VANGUARD VALUE ETF

78,100$9.6M1.8%$121.52-4.92%
2 qtrssince 2022-Q2
Decreased
0
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

56,300$7.7M1.4%$135.92-5.22%
2 qtrssince 2022-Q2
Decreased
0
$548.7M
AUM
10
Positions
Q3 2022
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q3'22
New38%Increased5%Decreased40%Exited16%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.4 quarters
<1Q20%1-4Q50%1-2Y0%2Y+30%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $548.7M across 10 positions as of Q3 2022. Top holdings: IVV (29.4%), AGG (18.5%), IWF (17.2%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 1.5/5.0.

Q3 2022 Summary

Added 2 new positions, exited 1, increased 2, trimmed 6. Top move: IWF (NEW, conviction 95). Portfolio: $549M across 10 positions.

Top holdings by portfolio weight

Total AUM$549M
IVV29.38%
AGG18.52%
IWF17.19%
TLT13.13%
VUG9.04%
VANGUARD BD 3.85%
VCSH3.77%
IGSB1.97%
VTV1.76%
IWD1.40%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record85
Conviction50
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVANGUARD GROWTH ETF
Q3 2025 Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQ
Q4 2025 Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVANGUARD FTSE EMERGING MARKETS
Q1 2026 Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used